2020
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda
Springer SA, Barocas J, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda. The Journal Of Infectious Diseases 2020, 222: s230-s238. PMID: 32877568, PMCID: PMC7467230, DOI: 10.1093/infdis/jiz673.Peer-Reviewed Original ResearchMeSH KeywordsBacteremiaCommunicable Disease ControlFederal GovernmentHealth PolicyHepatitis BHepatitis CHIV InfectionsHuman RightsHumansIllicit DrugsInfectious Disease MedicineIntersectoral CollaborationInvasive Fungal InfectionsOpioid EpidemicPatient AdvocacyPreventive Health ServicesPublic Health AdministrationSocieties, MedicalState GovernmentSubstance-Related DisordersUnited StatesConceptsIllicit drug useInfectious diseasesAddiction specialistsDrug useSubstance use disorder treatmentUse disorder treatmentHarm reduction toolHIV physiciansInfectious complicationsEvidence-based practiceHIV epidemicOpioid epidemicCare continuumAssociated InfectionsTreatment servicesDisorder treatmentOpioid crisisDiseaseIDSAReview programEpidemicFurther disseminationHuman rights-based responseAdvocacy agendaMorbidity
2011
Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components
Springer SA, Spaulding AC, Meyer JP, Altice FL. Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components. Clinical Infectious Diseases 2011, 53: 469-479. PMID: 21844030, PMCID: PMC3156144, DOI: 10.1093/cid/cir446.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAnti-HIV AgentsCase ManagementHIV InfectionsHumansMental DisordersPrisonersPrisonsPublic Health AdministrationRisk FactorsSubstance-Related DisordersUnited StatesConceptsCombination antiretroviral therapyPublic health implicationsTreatment outcomesPoor HIV treatment outcomesHuman immunodeficiency virus (HIV) infectionImmunodeficiency syndrome prevalenceHIV treatment outcomesImmunodeficiency virus infectionHealth implicationsMental illness treatmentSubstance use disordersCase management servicesAntiretroviral therapySecondary preventionSyndrome prevalenceTransitional careImmunological outcomesCriminal justice populationsVirus infectionIllness treatmentUse disordersHIVMental illnessAlcohol useMedical insurance